Your browser doesn't support javascript.
loading
Trial Design and Optimal Determination of CNS Activity of Small Molecule Targeted Therapy in NSCLC.
Jennings, Elaine M; Camidge, D Ross; Gadgeel, Shirish; Barker, Scott.
Affiliation
  • Jennings EM; Eli Lilly and Company, Indianapolis, IN.
  • Camidge DR; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO. Electronic address: ROSS.CAMIDGE@CUANSCHUTZ.EDU.
  • Gadgeel S; Division of Hematology and Oncology, Department of Internal Medicine, Henry Ford Cancer Institute/ Henry Ford Health, Detroit, MI.
  • Barker S; Eli Lilly and Company, Indianapolis, IN.
Clin Lung Cancer ; 25(2): 91-99, 2024 03.
Article in En | MEDLINE | ID: mdl-38135566
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Central Nervous System Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: India Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Central Nervous System Neoplasms / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2024 Document type: Article Affiliation country: India Country of publication: Estados Unidos